EP 1420747 A4 20100602 - BENZOQUINONE ANSAMYCINS
Title (en)
BENZOQUINONE ANSAMYCINS
Title (de)
BENZOCHUINONANSAMYCINE
Title (fr)
ANSAMYCINE BENZOQUINONE
Publication
Application
Priority
- US 0224891 W 20020805
- US 31007901 P 20010806
- US 38925502 P 20020614
- US 39392902 P 20020703
- US 39527502 P 20020712
Abstract (en)
[origin: WO03013430A2] The invention relates to benzoquinone ansamycin analogs useful for the treatment of cancer and other diseases or conditions characterized by undesired cellular proliferation or hyperproliferation. Therapies involving the administration of such benzoquinone ansamycin analogs, optionally in combination with an inhibitor of an HSP90 client protein, are useful to treat cancer and non-cancerous disease conditions.
IPC 1-7
IPC 8 full level
A61P 35/00 (2006.01); C07D 225/06 (2006.01); C07D 491/08 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); C07D 225/06 (2013.01); C07D 491/08 (2013.01)
Citation (search report)
- [A] US 4261989 A 19810414 - SASAKI KAZUYA, et al
- [A] WO 9501342 A1 19950112 - PFIZER [US], et al
- [X] DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1981, XP002577770, retrieved from STN Database accession no. 1981:71490
- [A] Z. LIAO E T AL, ACTA PHARMACEUTICA SINICA, vol. 36, no. 8, August 2001 (2001-08-01), pages 569 - 575, XP008045475 & JP S55111419 A 19800828 - KAKEN KAGAKU KK
- See references of WO 03013430A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
WO 03013430 A2 20030220; WO 03013430 A3 20040304; AU 2002330998 A1 20030224; EP 1420747 A2 20040526; EP 1420747 A4 20100602
DOCDB simple family (application)
US 0224891 W 20020805; AU 2002330998 A 20020805; EP 02768436 A 20020805